Related references
Note: Only part of the references are listed.The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain
W. A. Garcia-Suastegui et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Risk prediction of hepatotoxicity in paracetamol poisoning
Anselm Wong et al.
CLINICAL TOXICOLOGY (2017)
Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen
Anne van Rongen et al.
CLINICAL PHARMACOKINETICS (2016)
Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing
Lukas Witt et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
1H-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents
Cilius Esmann Fonvig et al.
PLOS ONE (2015)
A Review of the Toxicologic Implications of Obesity
Matthew Zuckerman et al.
JOURNAL OF MEDICAL TOXICOLOGY (2015)
Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the Psi parameter
S. Chomchai et al.
CLINICAL TOXICOLOGY (2014)
Association between Class III Obesity (BMI of 40-59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies
Cari M. Kitahara et al.
PLOS MEDICINE (2014)
1H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems
Elizaveta Chabanova et al.
ABDOMINAL IMAGING (2013)
NICE guideline: feverish illness in children-assessment and initial management in children younger than 5 years
Tessa Davis
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2013)
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Margreke J. E. Brill et al.
CLINICAL PHARMACOKINETICS (2012)
MR spectroscopy of liver in overweight children and adolescents: Investigation of 1H T2 relaxation times at 3 T
Elizaveta Chabanova et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Altered xanthine oxidase and N-acetyltransferase activity in obese children
Manoj S. Chiney et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
What is the right dose for children?
Massimo Cella et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis
Heather M. Patton et al.
GASTROENTEROLOGY (2008)
Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis
Haithem Chtioui et al.
LIVER INTERNATIONAL (2007)
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease
MG Emery et al.
HEPATOLOGY (2003)
Hepatic cytochrome p450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis
N Chalasani et al.
HEPATOLOGY (2003)
Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans
ZQ Wang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values
K Nysom et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Share Paper
